ANXA2 and hepatocellular carcinoma: Annexin A2 also promotes immune escape of hepatocellular carcinoma, by upregulation of immune checkpoint molecules, and decreased expression of effector factors, including perforin, granzyme B (GZMB), interferon-γ, and TNF-α [17].